ACRV icon

Acrivon Therapeutics
ACRV

Overview Fund Trends Analyst Outlook Journalist POV

18 hedge funds and large institutions have $170M invested in Acrivon Therapeutics in 2022 Q4 according to their latest regulatory filings, with 18 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

Holders
18
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$55.4M
2
+$34.7M
3
+$19M
4
Citadel Advisors
Citadel Advisors
Florida
+$18.2M
5
Marshall Wace
Marshall Wace
United Kingdom
+$14.1M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$55.4M
2
$34.7M
3
$19M
4
$18.2M
5
$14.1M
6
$9.99M
7
$9.48M
8
$4.44M
9
$3.27M
10
$545K
11
$447K
12
$248K
13
$226K
14
$180K
15
$54.7K
16
$47K
17
$10K
18
$2K